HLA Typing Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Global HLA Typing for Transplant Market is Segmented by Product Type (Instruments, Reagents and Consumables, and Software and Services), by Application (Diagnosis, Research) by End User (Hospitals, Research Laboratories, Other End Users), and by Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Size and Forecasts are Provided in Terms of Value (USD Million) for the Above Segments.

HLA Typing Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

HLA Typing Market Size

HLA Typing Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 0.80 Billion
Market Size (2030) USD 1.14 Billion
CAGR (2025 - 2030) 7.15 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

HLA Typing Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global HLA Typing Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

HLA Typing Market Analysis

The Global HLA Typing Market size is estimated at USD 0.80 billion in 2025, and is expected to reach USD 1.14 billion by 2030, at a CAGR of 7.15% during the forecast period (2025-2030).

COVID-19 impacted the HLA typing market to a great extent due to the use of HLA typing in identifying the severity of COVID-19 diseases. For instance, according to a study published in 2021 by the European Journal of Medical Research, the HLA-A*11:01, HLA-B*51:01, and HLA-C*14:02 alleles were significantly associated with severe disease or worse outcomes. This led to increased adoption of HLA typing for COVID-19 patients to understand the severity of the disease, driving the market growth. However, the market growth is stabilizing in the current scenario after COVID-19 as the worldwide restrictions have eased down and disease screening services have been resumed.

The factors such as the growing burden of genetic diseases and the increasing number of organ transplants aid as a major contributors to the market growth. Furthermore, advancements in the products related to HLA typing are also expected to boost market growth.

According to the CDC data updated in May 2022, Sickle Cell Disease (SCD) affects approximately 100,000 Americans in 2021. Furthermore, according to news-medical.net updated in August 2022, thalassemia affects around 4.4 out of every 10,000 live births throughout the world every year. Such a high prevalence of genetic diseases across the globe will lead to increased adoption of HLA testing for the identification of genetic diseases, driving market growth.

Furthermore, rising initiatives from the key market players for the launch of innovative products into the market will further be expected to drive the growth of this market. For instance, in November 2021, NGeneBio a South Korean diagnostics firm received CE-IVD marking for its next-generation sequencing-based human leukocyte antigen (HLA) typing assay. This HLAaccuTest detects 11 HLA gene loci to verify the histocompatibility between bone marrow or organ donors and recipients before transplantation. This will lead to increased adoption of HLA typing tests during organ and bone marrow transplantation propelling the market growth.

In addition, rising awareness of HLA typing is also expected to bolster market growth. For instance, in August 2021, a free HLA typing test camp was conducted at Dr. Vinky Rughwani Thalassemia and Sickle Cell Center in collaboration with Sankalp India Foundation. Such campaigns will therefore lead to increased adoption of HLA typing for genetic testing, driving the market growth.

Thus, the rising prevalence of diseases and the developments in HLA typing are expected to drive market growth. However, small size of study population and ethical concern and stringent regulatory framework are expected to hinder the growth of the market.

HLA Typing Industry Overview

The market for HLA typing market is slightly fragmented due to the rise in the number of product launches by many biotechnological companies, the rise in innovative biotechnological companies, rise in genetic testing, among others. Some of the key players that are expected to dominate the HLA Typing market include Thermofisher Scientific Inc., Qiagen, Illumina Inc., F. Hoffman-La Roche Limited, Bio-Rad Laboratories Inc., Beckton, Dickinson and Company, TBG Diagnostics Ltd, Takara Bio Inc., GenDX, and Omixon Inc, among others.

HLA Typing Market Leaders

  1. Illumina, Inc.

  2. Qiagen

  3. Thermofisher Scientific, Inc.

  4. Omixon, Inc.

  5. Becton, Dickinson and Company

  6. *Disclaimer: Major Players sorted in no particular order
HLA Typing Market
Need More Details on Market Players and Competiters?
Download PDF

HLA Typing Market News

  • In May 2022, Mylab Discovery Solutions launched DiscoverSeries HLAB*27 detection kit, an in-vitro diagnostic test for Ankylosing Spondylitis (AS).
  • In April 2022, Genome Diagnostics (GenDx), a Dutch molecular diagnostics firm received approval from Canadian regulators for the invitro diagnostic use of its NGSgo-MX11-3 human leukocyte antigen genotyping test.

HLA Typing Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Genetic Diseases
    • 4.2.2 Increasing Number of Organ Transplantation
    • 4.2.3 Rising Government Initiatives Related to Advanced Diagnostics
  • 4.3 Market Restraints
    • 4.3.1 Small Size of Study Population and Ethical Concern
    • 4.3.2 Stringent Regulatory Framework
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product and Service
    • 5.1.1 Instruments
    • 5.1.2 Reagents and Consumables
    • 5.1.3 Softwares and Services
  • 5.2 By Application
    • 5.2.1 Diagnosis
    • 5.2.2 Research
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Research Laboratories
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Beckton, Dickinson and Company
    • 6.1.2 Bio-Rad Laboratories Inc.
    • 6.1.3 F. Hoffman-La Roche Limited
    • 6.1.4 GenDX
    • 6.1.5 Illumina Inc.
    • 6.1.6 Omixon Inc.
    • 6.1.7 Qiagen
    • 6.1.8 Takara Bio Inc.
    • 6.1.9 TBG Diagnostics Ltd
    • 6.1.10 Thermofisher Scientific Inc.
    • 6.1.11 CareDx
    • 6.1.12 Biofortuna
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

HLA Typing Industry Segmentation

HLA typing is referred to as genetic testing that identifies variations in the immune system of the body. This test is used to match patients and donors for bone marrow or cord blood transplants. HLA typing is used is to find out which people will be able to provide the safest tissue transplant. The HLA Typing Market is segmented By Product Type (Instruments, Reagents and Consumables, and Software and Services), Application (Diagnosis, Research) End User (Hospitals, Research Laboratories, Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product and Service Instruments
Reagents and Consumables
Softwares and Services
By Application Diagnosis
Research
By End User Hospitals
Research Laboratories
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

HLA Typing Market Research FAQs

How big is the Global HLA Typing Market?

The Global HLA Typing Market size is expected to reach USD 0.80 billion in 2025 and grow at a CAGR of 7.15% to reach USD 1.14 billion by 2030.

What is the current Global HLA Typing Market size?

In 2025, the Global HLA Typing Market size is expected to reach USD 0.80 billion.

Who are the key players in Global HLA Typing Market?

Illumina, Inc., Qiagen, Thermofisher Scientific, Inc., Omixon, Inc. and Becton, Dickinson and Company are the major companies operating in the Global HLA Typing Market.

Which is the fastest growing region in Global HLA Typing Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global HLA Typing Market?

In 2025, the North America accounts for the largest market share in Global HLA Typing Market.

What years does this Global HLA Typing Market cover, and what was the market size in 2024?

In 2024, the Global HLA Typing Market size was estimated at USD 0.74 billion. The report covers the Global HLA Typing Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global HLA Typing Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

HLA Typing Industry Report

Statistics for the 2025 Global HLA Typing market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global HLA Typing analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.